HuiLing (Phoebe) Wang

• Identify and explore clinical service opportunities of pharmaceutical, biotech, drugs and medical devices company from China, Taiwan and Korea to EU, US and Australia for clinical trial conduction.
• Liaise with customers and operation teams to understand customer needs and recommend appropriate solutions.
• Expand cross-functional organizational capacity by collaborating across departments on priorities, functions and common goals.
• Develop new opportunities by effectively communicating product lines to leading international corporations
• Establish new accounts through existing relationship, webinar lists and personal visits to potential customers.

Achievements:

- Contracted China based biotech companies to conduct clinical trial in Australia for Phase I study.

- Contracted Cell & Gene Therapy companies for service of INTERACT/pre-IND meeting with US FDA and PRIME with the EMA.

- Contracted Taiwan based pharmaceuticals and biotech companies for clinical service of EoP2 meetings with US FDA and 505(b)(2) application and clinical trial in the US.

• Actively prospects and leverages potential new business opportunities within specified Customer/Accounts.
• Cultivate strong, long-term relationships with key decision-makers with Account and develops deep knowledge of Customer/Account organization.
• Lead entire sales process, including identifying appropriate teams for pitch and preparing and leading sales presentation.
• Coordinate with proposal development team to develop proposal and to finalize strategy and pricing.
• Handle follow-up related to sales and facilitates completion of contractual documents.
• Ensure appropriate hand-off to project team by transferring knowledge on Customer/Account needs and expectations.
• Coordinates with Project Managers/Directors to ensure Customer/Account needs are being met and address concerns/issues in timely manner.

Contract Sales Achievement:

• The contract sales of until September,2021, around USD 8M
• The contract sales of 2020 year, USD 4.1M (due to COVID-19 impact)
• The contract sales of the second half of 2019 year, USD 4.4M
• Build-up and contracted with a MNC pharmaceutical company
• Lead new business service for Real-world Pharmacovigilance service stand along

• Efficiently support and deliver all business activities within defined territory
• Lead budget development process and timelines to support proposal submission and scope change process
• Identify and target new clients
  
• Make strategic plan and integrate with each department for new business opportunity
  
• Contribute to marketing plans, customer awareness campaigns, Supports business strategy, goals and objectives achievements
  
• In-conjunction with other individuals within Clinipace (e.g., Country Manager/Country Head, Vendor Management Manager) help to support identification of new preferred vendors

Contract Sales Achievement:

• 2016 Remain the amount of 2015 contract sales, USD $2 M
• 2017 Contract sales grow up to 280% , reach to USD $5.6 M, with a regional study and 6 new clients
• 2018 Contract sales remain the amount of 2017 and develop 4 new clients for US IND application

• Develop budget and study proposal in response to sponsor's RFP/ RFI.
  
• Develop change order in accordance with Project Manager's instruction.
  
• Utilize territory management and customer management to develop new customer profile.
  
• Coordinate and integrate with each department for case bidding
  

Contract Sales Achievement:

• 2013 Growth: 28% • 2014 Growth:75%

Develop Quoting Experiences:

• Phase I : over 15 study • Phase II: over 20 study

• Phase III: over 15 study • Phase IV and others: over 20 study

• Reach out to customer leads through cold calling
  
• Present, promote and sell products/services using solid arguments to existing and prospective customers
  
• Establish, develop and maintain positive business and customer relationships
  
• Achieve sales targets and outcomes within schedule
  

Achievement : Start Dash competition qualified in 2009

• Isolated and purified the yeast prion [PSI+] and Examined biophysical properties of different prion strains.

• Establish a measurement tool

Have 2 Publications :

• Chang H-Y, Lin J-Y, Lee H-C, Wang H-L, King C-Y. Strain-specific sequences required for yeast [PSI+] prion propagation. Proc. Natl. Acad. Sci. USA 105:13345– 13350.
• Chang H-Y, Wang H-L, King C-Y. Transformation of yeast by infectious prion
• Particles. Method 39:68-71